Tricks and tips for target volume definition and delineation in breast cancer: lessons learned from ESTRO breast courses.

[1]  Hannah M. Dahn,et al.  The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review. , 2021, Critical reviews in oncology/hematology.

[2]  M. S. Thomsen,et al.  Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial , 2021, Clinical and translational radiation oncology.

[3]  T. Kühn,et al.  A multidisciplinary approach for autologous breast reconstruction: A narrative (re)view for better management. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  T. Kühn,et al.  A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges , 2021, Breast.

[5]  X. Pan,et al.  Dosimetric Parameters Associated with Radiation-Induced Esophagitis in Breast Cancer Patients Undergoing Regional Nodal Irradiation. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  E. van Limbergen,et al.  Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial. , 2020, The Lancet. Oncology.

[7]  L. Boersma,et al.  Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation. , 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

[8]  J. Michalski,et al.  Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  A. Nichol,et al.  PET/CT of breast cancer regional nodal recurrences: an evaluation of contouring atlases , 2020, Radiation oncology.

[10]  E. Sawyer,et al.  Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial , 2020, The Lancet.

[11]  A. Taghian,et al.  Comparison of nodal target volumes definition in breast cancer radiotherapy according to RTOG versus ESTRO atlases. A practical review from the TransAtlantic Radiation Oncology Network (TRONE). , 2020, International journal of radiation oncology, biology, physics.

[12]  M. Duma.  An Update on Regional Nodal Irradiation: Indication, Target Volume Delineation, and Radiotherapy Techniques , 2020, Breast Care.

[13]  C Daniel Mullins,et al.  Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol , 2019, BMJ Open.

[14]  H. Park,et al.  Risk of Lymphedema Following Contemporary Treatment for Breast Cancer , 2019, Annals of surgery.

[15]  M. Duma,et al.  FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients. , 2019, International journal of radiation oncology, biology, physics.

[16]  M. Duma,et al.  Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Ik Jae Lee,et al.  Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  M. Duma,et al.  Deep-Inspiration Breath-Hold Radiation Therapy in Breast Cancer: A Word of Caution on the Dose to the Axillary Lymph Node Levels. , 2018, International journal of radiation oncology, biology, physics.

[19]  A. Giuliano,et al.  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial , 2017, JAMA.

[20]  M. S. Thomsen,et al.  Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Kazem Rahimi,et al.  A cardiac contouring atlas for radiotherapy , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Ik Jae Lee,et al.  Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volume. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  A. Szabo,et al.  Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer. , 2016, International journal of radiation oncology, biology, physics.

[24]  G. Gupta,et al.  Helical tomotherapy for bilateral breast cancer: Clinical experience. , 2016, Breast.

[25]  Talia K. Ben-Jacob,et al.  Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial , 2010, Annals of surgery.

[26]  Mechthild Krause,et al.  ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  V. Remouchamps,et al.  Vessel based delineation guidelines for the elective lymph node regions in breast cancer radiation therapy - PROCAB guidelines. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  Shulian Wang,et al.  Mapping Patterns of Ipsilateral Supraclavicular Nodal Metastases in Breast Cancer: Rethinking the Clinical Target Volume for High-risk Patients. , 2015, International journal of radiation oncology, biology, physics.

[29]  Laurence Collette,et al.  Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. , 2015, The New England journal of medicine.

[30]  A. Kuten,et al.  Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  William Small,et al.  Contouring Guidelines for the Axillary Lymph Nodes for the Delivery of Radiation Therapy in Breast Cancer: Evaluation of the RTOG Breast Cancer Atlas. , 2013, International journal of radiation oncology, biology, physics.

[32]  Mechthild Krause,et al.  ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  T. Whelan,et al.  Regional Nodal Irradiation in Early-Stage Breast Cancer. , 2015, The New England journal of medicine.

[34]  Tibor Major,et al.  Recommendations from GEC ESTRO Breast Cancer Working Group (I): Target definition and target delineation for accelerated or boost Partial Breast Irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  R. Mansel,et al.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.

[36]  H. Bartelink,et al.  A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique , 2014 .

[37]  Daniel Berger,et al.  Four years with FALCON - an ESTRO educational project: achievements and perspectives. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  Sasa Mutic,et al.  Standardizing naming conventions in radiation oncology. , 2012, International journal of radiation oncology, biology, physics.

[39]  Bernard T. Lee,et al.  High Body Mass Index and Smoking Predict Morbidity in Breast Cancer Surgery: A Multivariate Analysis of 26,988 Patients From the National Surgical Quality Improvement Program Database , 2012, Annals of surgery.

[40]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[41]  A. Luini,et al.  Analysis of local and regional recurrences in breast cancer after conservative surgery. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[42]  A. Luini,et al.  The evolution of the conservative approach to breast cancer. , 2007, Breast.

[43]  Richard Symonds-Tayler,et al.  Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  I. Sayek,et al.  Re-evaluation of Axillary Skip Metastases in the Era of Sentinel Lymph Node Biopsy in Breast Cancer , 2006, Surgery Today.

[45]  E. Rutgers,et al.  Lymphatic Drainage Patterns From the Breast , 2004, Annals of surgery.

[46]  E. Rutgers,et al.  Should the Hunt for Internal Mammary Chain Sentinel Nodes Begin? An Evaluation of 150 Breast Cancer Patients , 2003, Annals of Surgical Oncology.

[47]  D. Schultz,et al.  Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. , 1990, International journal of radiation oncology, biology, physics.

[48]  G. Hal,et al.  Distribution of axillary node metastases bylevel of invasion , 1987 .

[49]  A. Luini,et al.  Distribution of axillary node metastases by level of invasion. An analysis of 539 cases , 1987, Cancer.

[50]  C. Balch,et al.  Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. , 1984, Surgery, gynecology & obstetrics.

[51]  M. Lesser,et al.  Discontinuous or “Skip” Metastases in Breast Carcinomae: Analysis of 1228 Axillary Dissections , 1983, Annals of surgery.